NCJ Number
310575
Date Published
2025
Length
5 pages
Abstract
This report provides up-to-date information regarding the status of NPS benzodiazepine prevalence and positivity in the United States.
Novel psychoactive substances (NPS), including NPS benzodiazepines, continue to pose great challenges for forensic scientists, clinicians, and public health and safety personnel. NPS benzodiazepines have been implicated in an increasing number of adverse health events, marked by emergency room admissions and death investigations, especially when ingested in combination with opioids. Maintaining a current scope of analysis can be challenging, requiring comprehensive analytical methodologies and reference materials for identification(s). (Publisher abstract provided.)
Date Published: January 1, 2025
Downloads
Similar Publications
- A Systematic Study of Liquid Chromatography to Separate Eighteen Natural Cannabinoids for Potency Testing of Hemp-Based Products Using Diode Array Detector and Electrospray Ionization Mass Spectrometry
- EVALUATING THE SUCCESS OF A KINETIC MODEL TO PREDICT CHROMATOGRAMS OF IGNITABLE LIQUIDS UNDER DIFFERENT EVAPORATION MODES AND IN THE PRESENCE OF PASSIVE-HEADSPACE EXTRACTION
- Marijuana Legalization and Crime Clearance Rates: Testing Proponent Assertions in Colorado and Washington State